AllianceBernstein’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-62,178
Closed -$4.48M 3377
2020
Q4
$4.48M Sell
62,178
-52,917
-46% -$2.77M ﹤0.01% 1546
2020
Q3
$5.25M Sell
115,095
-19,555
-15% -$817K ﹤0.01% 1316
2020
Q2
$6.08M Buy
134,650
+4,840
+4% +$217K ﹤0.01% 1230
2020
Q1
$5M Buy
129,810
+15,210
+13% +$700K ﹤0.01% 1180
2019
Q4
$5.31M Buy
114,600
+250
+0.2% +$10.8K ﹤0.01% 1401
2019
Q3
$4.66M Sell
114,350
-7,600
-6% -$328K ﹤0.01% 1426
2019
Q2
$5.87M Buy
121,950
+71,350
+141% +$3.75M ﹤0.01% 1325
2019
Q1
$3.17M Buy
50,600
+700
+1% +$48.1K ﹤0.01% 1647
2018
Q4
$2.98M Sell
49,900
-300
-0.6% -$18K ﹤0.01% 1604
2018
Q3
$3.23M Hold
50,200
﹤0.01% 1591
2018
Q2
$2.26M Buy
50,200
+12,700
+34% +$506K ﹤0.01% 1825
2018
Q1
$1.16M Hold
37,500
﹤0.01% 2168
2017
Q4
$1.12M Hold
37,500
﹤0.01% 2196
2017
Q3
$1.24M Sell
37,500
-37,750
-50% -$1.31M ﹤0.01% 2159
2017
Q2
$2.52M Buy
75,250
+43,050
+134% +$1.28M ﹤0.01% 1677
2017
Q1
$932K Hold
32,200
﹤0.01% 2272
2016
Q4
$720K Hold
32,200
﹤0.01% 2420
2016
Q3
$598K Buy
32,200
+10,500
+48% +$198K ﹤0.01% 2466
2016
Q2
$354K Buy
+21,700
New +$319K ﹤0.01% 2637
2015
Q2
Sell
-5,300
Closed -$47K 3548
2015
Q1
$47K Buy
5,300
+2,500
+89% +$25.3K ﹤0.01% 3147
2014
Q4
$28K Hold
2,800
﹤0.01% 3186
2014
Q3
$19K Sell
2,800
-2,800
-50% -$19.6K ﹤0.01% 3212
2014
Q2
$40K Buy
+5,600
New +$44.6K ﹤0.01% 3145

Other funds holding BEAT

AllianceBernstein's BEAT Position: Q1 2021 in Review

AllianceBernstein sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 62,178 shares — an estimated $4.48M sold.

AllianceBernstein first reported a position in BEAT in Q2 2014 and held it in 23 quarters. The position peaked at $6.08M in Q2 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • AllianceBernstein reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • AllianceBernstein sold 62,178 BioTelemetry, Inc. shares in Q1 2021, an estimated $4.48M.
  • AllianceBernstein first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 23 quarters.
  • AllianceBernstein's BioTelemetry, Inc. position peaked at $6.08M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on AllianceBernstein's 13F filing for Q1 2021, filed 6 May 2021.